Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon 403-720, South Korea.
Metabolism. 2011 Jan;60(1):107-13. doi: 10.1016/j.metabol.2009.12.021. Epub 2010 Jan 25.
Fructose-1,6-bisphosphatase (FBPase) deficiency is an autosomal recessive disorder caused by a mutation of the fructose-1,6-bisphosphatase 1 (FBP1) gene and results in impaired gluconeogenesis. We describe a male patient with typical FBPase deficiency who presented with hypoglycemia and lactic acidosis. The FBPase activity in his peripheral leukocytes and liver was very low. We amplified and sequenced the entire FBP1 coding region of the patient and his family members. Direct and allele-specific sequence analysis of the FBP1 gene revealed that the proband had a compound heterozygote for the G164S and 838delT, which he inherited from his carrier parents. His father and mother had heterozygous 838delT and G164S mutations, respectively, without any symptoms of hypoglycemia. Gene tracking within the family revealed that his elder sister had a heterozygous G164S mutation without symptoms of hypoglycemia. A G164S mutation of FBP1 in a heterozygous pattern (G164S and InsG960_961) has been reported previously, but the heterozygous 838delT mutation is novel. Transient transfection studies using COS-7 cells demonstrated that FBPase proteins with G164S or 838delT mutations were enzymatically inactive. In conclusion, we report a new case of molecular diagnosis of FBPase deficiency and provide evidence that impaired FBPase activity may be caused by novel compound heterozygous mutations in the FBP1 gene.
果糖-1,6-二磷酸酶(FBPase)缺乏症是一种常染色体隐性遗传疾病,由果糖-1,6-二磷酸酶 1(FBP1)基因突变引起,导致糖异生受损。我们描述了一位男性患者,其具有典型的 FBPase 缺乏症,表现为低血糖和乳酸性酸中毒。他外周白细胞和肝脏中的 FBPase 活性非常低。我们扩增并测序了患者及其家庭成员的整个 FBP1 编码区。对 FBP1 基因的直接和等位基因特异性序列分析显示,该先证者携带 G164S 和 838delT 的复合杂合突变,分别从其携带者父母遗传而来。他的父亲和母亲分别携带杂合的 838delT 和 G164S 突变,但没有任何低血糖症状。对家族内的基因追踪显示,他的姐姐携带杂合的 G164S 突变,没有低血糖症状。以前已经报道过 FBP1 基因的杂合 G164S 突变(G164S 和 InsG960_961),但杂合 838delT 突变是新颖的。使用 COS-7 细胞进行的瞬时转染研究表明,具有 G164S 或 838delT 突变的 FBPase 蛋白酶活性丧失。总之,我们报告了一例新的 FBPase 缺乏症的分子诊断病例,并提供证据表明,新型 FBP1 基因突变的复合杂合突变可能导致 FBPase 活性受损。